04/28/2015
https://www.congress.gov...
"I believe that more must be done to improve both transparency and the oversight of drug products after they reach the market to ensure safety."
"It's critical for the products that are approved by the FDA to be of the highest safety and efficacy standards."
"However, still, too many Americans face barriers to getting access to high-quality treatment options for mental health issues."
"We know that in recent years we have made great strides in improving access to insurance coverage in this space with the Mental Health Parity and Addiction Equity Act and also the Affordable Care Act."